You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

abaloparatide-SC

Showing 26 - 50 of 1,483
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

ST Elevation Myocardial Infarction Trial in Isehara (Percutaneous coronary intervention)

Enrolling by invitation
  • ST Elevation Myocardial Infarction
  • Percutaneous coronary intervention
  • Isehara, Kanagawa, Japan
    Tokai University Hospital
Nov 21, 2022

Healthy Volunteers Trial in Anaheim, Overland Park (BIIB107, Placebo)

Recruiting
  • Healthy Volunteers
  • Anaheim, California
  • +2 more
Jan 9, 2023

Relapsed or Refractory Multiple Myeloma Trial in Worldwide (Talquetamab, Daratumumab, Pomalidomide)

Not yet recruiting
  • Relapsed or Refractory Multiple Myeloma
  • Tucson, Arizona
  • +191 more
Aug 11, 2022

Human Immunodeficiency Virus Type 1 (HIV-1) Trial in Worldwide (Cabotegravir - Injectable Suspension (CAB LA), Rilpivirine -

Active, not recruiting
  • Human Immunodeficiency Virus Type 1 (HIV-1)
  • Cabotegravir - Injectable Suspension (CAB LA)
  • Rilpivirine - Injectable Suspension (RPV LA)
  • Macon, Georgia
  • +29 more
May 31, 2023

Healthy Volunteers Trial (ARGX-119, Placebo)

Not yet recruiting
  • Healthy Volunteers
  • ARGX-119
  • Placebo
  • (no location specified)
Jan 2, 2023

Migraine, MDD Trial in Worldwide (Fremanezumab, Placebo)

Completed
  • Migraine
  • Major Depressive Disorder
  • Little Rock, Arkansas
  • +63 more
Dec 7, 2022

Bullous Pemphigoid Trial (efgartigimod PH20 SC, Prednisone)

Not yet recruiting
  • Bullous Pemphigoid
  • (no location specified)
Dec 27, 2022

ST Elevation Myocardial Infarction Trial (Dutogliptin + Filgrastim, Placebo)

Not yet recruiting
  • ST Elevation Myocardial Infarction
  • Dutogliptin + Filgrastim
  • Placebo
  • (no location specified)
Jun 1, 2023

Crohn's Disease Trial in Seoul (Infliximab-Dyyb)

Not yet recruiting
  • Crohn's Disease
  • Seoul, Korea, Republic of
    Asan Medical Center
Oct 5, 2023

Healthy, Postbariatric Hypoglycemia Trial (MBX 1416 (Part A), MBX 1416 (Part B), Placebo)

Not yet recruiting
  • Healthy
  • Postbariatric Hypoglycemia
  • MBX 1416 (Part A)
  • +2 more
  • (no location specified)
Sep 11, 2023

Monkeypox Trial in Puerto Rico, United States (JYNNEOS)

Not yet recruiting
  • Monkeypox
  • JYNNEOS
  • Birmingham, Alabama
  • +13 more
Feb 13, 2023

Multiple Myeloma Trial (Iberdomide, Daratumumab/rHuPH20 Co-formulation)

Not yet recruiting
  • Multiple Myeloma
  • (no location specified)
Oct 25, 2023

Multiple Myeloma Trial in Worldwide (Dara SC, Dara IV)

Active, not recruiting
Has Results
  • Multiple Myeloma
  • Dara SC
  • Dara IV
  • Boston, Massachusetts
  • +145 more
Jan 17, 2023

Healthy Participants Study Trial in Brooklyn, Berlin, Harrow (Anifrolumab, Autoinjector, Accessorized Pre-Filled Syringe)

Recruiting
  • Healthy Participants Study
  • Brooklyn, Maryland
  • +2 more
Dec 22, 2022

Rheumatoid Arthritis, Systemic Lupus Erythematosus Trial (GS-0272, Placebo)

Not yet recruiting
  • Rheumatoid Arthritis
  • Systemic Lupus Erythematosus
  • (no location specified)
Sep 4, 2023

Crohn Disease, Colitis, Ulcerative Trial (TEV-48574 Dose Regimen A, TEV-48574 Dose Regiment B)

Recruiting
  • Crohn Disease
  • Colitis, Ulcerative
  • TEV-48574 Dose Regimen A
  • TEV-48574 Dose Regiment B
  • Kissimmee, Florida
    Teva Investigational Site 15357
Feb 2, 2023

Hemophilia A Trial in Worldwide (Emicizumab)

Active, not recruiting
  • Hemophilia A
  • Beijing City, China
  • +12 more
Nov 21, 2022

Rheumatoid Arthritis Trial (AZD6912, Placebo)

Not yet recruiting
  • Rheumatoid Arthritis
  • (no location specified)
Oct 30, 2023

Alpha1-Antitrypsin Deficiency Trial in United States (Alpha-1 15%, Liquid Alpha1-Proteinase Inhibitor (Human))

Recruiting
  • Alpha1-Antitrypsin Deficiency
  • Alpha-1 15%
  • Liquid Alpha1-Proteinase Inhibitor (Human)
  • Gainesville, Florida
  • +5 more
Jan 13, 2023

Systemic Lupus Erythematosus, Healthy Volunteers Trial in United States (BIIB059, Placebo)

Completed
  • Systemic Lupus Erythematosus
  • Healthy Volunteers
  • BIIB059 (litifilimab)
  • Placebo
  • Anniston, Alabama
  • +4 more
Jan 30, 2023

IBD Trial in Paris (Biocollection)

Not yet recruiting
  • Inflammatory Bowel Diseases
  • Biocollection
  • Paris, France
    Saint Antoine Hospital Service de Gastroentérologie et Nutrition
Feb 1, 2023

Metastatic NSCLC Trial (Pembrolizumab coformulated with hyaluronidase, Pemetrexed, Cisplatin)

Not yet recruiting
  • Metastatic Non-small Cell Lung Cancer
  • Pembrolizumab coformulated with hyaluronidase
  • +6 more
  • (no location specified)
Jan 27, 2023

Migraine Trial (Fremanezumab, Placebo)

Not yet recruiting
  • Migraine
  • (no location specified)
Aug 12, 2022

Plasma Cell Myeloma Recurrent Trial in Australia, Chile (Isatuximab IV, Isatuximab SC, Dexamethasone)

Recruiting
  • Plasma Cell Myeloma Recurrent
  • Isatuximab IV
  • +3 more
  • Salt Lake City, Utah
  • +33 more
Jan 16, 2023

Generalized Myasthenia Gravis Trial in Carlsbad (Batoclimab 680 mg SC weekly, Batoclimab 340 mg SC weekly, Matching Placebo SC)

Recruiting
  • Generalized Myasthenia Gravis
  • Batoclimab 680 mg SC weekly
  • +3 more
  • Carlsbad, California
  • +14 more
Jan 31, 2023